Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Any modifications to the FDA-recommended titration schedule should be directed by your healthcare provider
PubMed Teramoto M, Yamagishi K, Muraki I, Tamakoshi A, Iso H
Mol Cell Endocrinol (2013) 366(2):21523
A well-rounded package includes access to fitness services
Conclusions: Semaglutide 2.4 mg is likely to be a cost-effective treatment option compared to liraglutide 3 mg for patients with a BMI 35 and at least one weight-related comorbidity in Greece
Irani, K., et al., Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts
US$ 20.71
US$ 22.20
US$ 20.21
US$ 24.68
US$ 20.17
US$ 21.12
US$ 21.93
US$ 28.43
US$ 20.14
